Innoviva is committed to building long-lasting value and improving patient care, by partnering with companies that advance innovative therapies. Anchored by its respiratory assets, Innoviva blends a unique fusion of operational industry expertise and financial insight to create a solid foundation for capital returns—and carve a path towards a healthier world for patients.

Manufactures and sells pharmaceuticals

Angelini produces, markets and distributes products for the health and well-being of people. Being close to the people and meeting their daily needs with effective and reliable products, of high quality, of great diffusion and accessibility, guaranteeing a constant and tangible well-being is the mission of Angelini. His goal is expressed in a clear vision: to be the spontaneous choice in the area of ​​health and daily well-being.

Roche Carolina, Inc., a subsidiary of Roche Holding AG, is a company headquartered in the United States involved in pharmaceutical preparations.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Perrigo API Ltd. develops and markets active pharmaceutical ingredients. The company was founded in 1987 and is headquartered in Bnei Brak, Israel.

Manufactures and sells pharmaceutical products

Nanjing Changao Pharmaceutical Science & Technology Co. Ltd., part of Shionogi & Co., Ltd., is a company headquartered in Nanjing, China, that manufactures and distributes pharmaceutical products. The firm was acquired by C&O Pharmaceutical Technology (Holdings) Ltd., a subsidiary of Shionogi & Co., Ltd. since December 2011, on January 11, 2006 for $0.09 million.

NATCO Pharma Ltd. engages in the business of pharmaceuticals with research, manufacturing and marketing of finished dosage formulations and active pharmaceutical ingredients. It operates through the following segments: Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients. The Domestic Formulations segment operates in the divisions of oncology, pharma specialties and CnD. The International Formulations segment exports its FDF products from India to several international geographies either through its local partners or directly through its subsidiaries such as in Canada and Brazil. The Active Pharmaceutical Ingredients segment is strategically important as it develops APIs for the captive consumption of many of NATCO's critical FDF products in addition to supplying to direct customers. The company was founded by Venkaiah Chowdary Nannapaneni in 1981 and is headquartered in Hyderabad, India.

Part of Fuan Pharmaceutical (Group) Co., Ltd., Ningbo Team Pharm Co. Ltd. is a company headquartered in Ningbo, China. The firm manufactures pharmaceutical products. It was acquired by Fuan Pharmaceutical (Group) Co., Ltd. on April 23, 2015 for $120.33 million.

Shanghai Zhaohui Pharmaceutical Co., Ltd., established on 1988-03-23, Business scope includes pharmaceutical production(See the license for details);Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Hana Pharm merged with Woocheon Pharm, established in 1958, to foster the 21st advanced pharmaceutical company in 1996. Hana Pharm reformed for human respect, a challenging spirit, and social contribution. In the last 20 years, they have been committed to developing better medicine, expanding GMP manufacturing facilities, and assuring GMP with a focus on investment and R&D to improve satisfaction from hospital care professionals and patients.” Above all, they have achieved sustained growth based on anesthetic and narcotic analgesics which are their company’s specialized products. Recently, they regard new drug development as a growth engine and have successfully executed the 3rd trial for remimazolam, an innovative new drug anesthetic.

Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP

National University Corp. Tokyo Medical & Dental University is a private company headquartered in Japan that operates as an national educational institution for dentistry.

Nisshin Pharma, Inc. is a holding company that produces and markets healthcare and pharmaceutical goods. Its products include Aqua Q10 powder, T-Ariin, Wheat Gluten Hydrolysate (WGH) Pro, and Bifi Colon. The company was founded in July 2001 and is headquartered in Tokyo, Japan.

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The Company maintains two wholly owned subsidiaries: Acadia Pharmaceuticals AB based in Malmo, Sweden and Acadia Pharmaceuticals A/S based in Denmark. The Company is developing a portfolio consisting of four product candidates, including the compound, pimavanserin, which it is developing for three separate neurological and psychiatric indications in collaboration with Biovail Laboratories International SRL (Biovail), a subsidiary of Biovail Corp. The indications are Parkinson's disease psychosis, which is in Phase III development, adjunctive therapy in schizophrenia, and Alzheimer's disease psychosis, for which it is initiating a Phase II feasibility study.

G.D. Searle, LLC is a wholly owned trademark of Pfizer. It is currently used mainly as a distribution trademark for various pharmaceuticals that were developed by G. D. Searle & Company (often referred to as Searle). Prior to its 1985 merger with Monsanto, Searle was a company focusing on life sciences, specifically pharmaceuticals, agriculture, and animal health.

Xiamen Kaierli Information Technology Co., Ltd., established on 2016-07-14, Business scope includes software development;Information system integration service;Data Processing and Storage Services;Information Technology Consulting Services;animation,comic design,make;Internet access and related services(Internet cafes not included);IC Design;Other unspecified information technology service industry(Items not subject to permit approval);other internet services(Items not subject to permit approval).

High Point Pharmaceuticals LLC is an American private company located in High Point, NC. The firm engages in pharmaceutical preparation. It was founded by Adnan M. M. Mjalli.